Stay updated on Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.

Latest updates to the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page revision updated from v3.6.4 to v3.6.5, signaling a new site revision behind the page. This likely includes minor fixes or enhancements without changing the study content or how the data is presented.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page revision indicator was updated from v3.6.3 to v3.6.4, reflecting an administrative update to the page. No substantive study content or functionality was changed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page shows a new revision label v3.6.3 replacing v3.6.2. This indicates a small deployment update and does not alter the study information.SummaryDifference0.1%

- Check50 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a newer version of the page documentation. This update does not modify the study details or user-visible content.SummaryDifference0.1%

- Check65 days agoChange DetectedThe page now indicates recruitment has ended and adds new help sections such as How to Read a Study Record, Common Questions, and How to Join a Study. The Intervention/Treatment label formatting was adjusted and the revision tag was updated to v3.6.0.SummaryDifference0.5%

- Check72 days agoChange DetectedThe page's revision tag changed from v3.5.4 to v3.5.5, reflecting a small metadata update to the record rather than substantive content changes.SummaryDifference0.1%

Stay in the know with updates to Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Texture Analysis Predicts Pembrolizumab Response in Melanoma: Clinical Trial page.